HEALTH programme EMERGENCIES HEALTH programme EMERGENCIES Mosquito-borne virus prevention and control: a global perspective Chikungunya 2017, Sapienza Universita di Roma 10 November 2017 Erika Garcia Mathematical Epidemiologist World Health Organization Geneva, Switzerland [email protected]
30
Embed
Mosquito-borne virus prevention and control: a global perspective · 2019. 3. 18. · Chikungunya and Dengue, Pakistan 2017 2 Outbreaks ... - Integrated surveillance (humans, animals,
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
• Estimated dengue age-standardized cases from 1990-2013 increased nearly 450%
HEALTH
programmeEMERGENCIES
HEALTH
programmeEMERGENCIES
Americas
27 November 2017
HEALTH
programmeEMERGENCIES
Chikungunya and Dengue, Pakistan 2017
2 Outbreaks
• Karachi Started Nov 2016 and continues. Health authorities estimate the total number of patients to be more than 30 000. The National Institutes of Health, Pakistan, and Armed Forces Institute of Pathology, Pakistan, confirmed 4000+ cases through qualitative RT-PCR.
• Dengue in Peshawar (Jul to Sept) also detected CHIKV. 50,000 cases
Chikungunya virus was found circulating in rodents in Pakistan as early as 1983. A few patients with chikungunya were also reported in Lahore during the 2011 dengue outbreak.
27 November 2017
HEALTH
programmeEMERGENCIES
Yellow fever, Angola, 2016
Location No. of cases Population
(million)
March Lo-Hi
Temp (°C)
Past reports
of Dengue
Beijing 4 11.51 -1 to 11 -
Fuzhou 2 2.124 9 to 19 2015
Shanghai 3 14.35 5 to 13 -
Source: MoH, China Meteorological Admnistration
• Dec '15 – Oct '16, 4347
susp cases, 377 deaths
• Spread to DRC, 2987
cases and 121 deaths
• Btwn 18 Mar - 4 Apr
2016, a total of 9
imported cases of YF
from Angola were
reported by NFP China.
Unvaccinated workers.
HEALTH
programmeEMERGENCIES
HEALTH
programmeEMERGENCIES
HEALTH
programmeEMERGENCIES
The context
27 November 2017
HEALTH
programmeEMERGENCIES
2. Surveillance and early detection
27 November 2017
- Early detection of Aedes-
borne outbreaks
- Integrated surveillance
(humans, animals, vectors)
- At-risk populations i.e,
pregnant women, elderly
- Utilize existing systems, i.e.,
AFP surveillance, Congenital
Rubella Surveillance,
Sentinel
HEALTH
programmeEMERGENCIES
Laboratory
27 November 2017
- Laboratory techniques: RT-PCR, ELISA or IF, PRNT
- Collection of patient samples: urine, saliva not just sera
- Challenges for Zika, et al: expertise about flaviviruses since
interpretation is complex. No WHO prequalified test
HEALTH
programmeEMERGENCIES
Clinical management
27 November 2017
• All arboviral diseases transmitted
by Ae. spp. (DENV, CHIKV, and
ZIKV) currently have no specific
treatment.
• But clinical management for each
is very important
• Studies needed to see the
severity of CHIKV
• No vaccine
HEALTH
programmeEMERGENCIES
“
… above all, the spread of Zika, the resurgence of dengue, and the emerging threat of Chikungunya are the price being paid for a massive policy failure that dropped the ball on
mosquito control in the 1970s.
Margaret ChanFormer Director-General, World Health Organization
Opening Address at World Health Assembly 69th sessionMay 2016
HEALTH
programmeEMERGENCIES
3. Global Vector Control Response 2017-
2030
REDUCE THE BURDEN AND
THREAT OF VECTOR-BORNE
DISEASES THAT AFFECT
HUMANS
ENABLING FACTORS
Country leadership
Advocacy, resource
mobilization and partner
coordination
Regulatory, policy
and normative support
Reduce incidence by 60%Reduce mortality by 75%By 2030
• Vector control methods applied in a community will depend on the local situation and preferences of the population.
• Suitable methods should be:– Effective
– Affordable
– Simple to understand and easy to apply
– Acceptable and compatible with local customs, attitudes and beliefs
– Safe to the user and the environment.
• Methods used in one place may not work in another place
• Social mobilization to eliminate breeding sites (targeting mothers, educating children through games), health promoters going to door to door for visits educating how to prevent disease, removing water containers.
HEALTH
programmeEMERGENCIES
Larval Control• Chemical control
– Organophosphates
– Pyrethroids
– Spinosad
– Insect Growth Regulators
• Biological control– Fishes
– Copepods
• Biocides –Bacillus thuringiensis var israelensis
• Environmental Control
HEALTH
programmeEMERGENCIES
Conditions for space spraying
• Precise location to be sprayed
• Distribution of case house(s)
• The case history [when is the first case (index case), movement pattern of cases, probable source of infection]
• Type of vector (Aedes aegypti vs Aedes albopictus or both)
• Major breeding sites
• Adequate trained supervisors
• Number of trained spray people available for mobilization
• Availability of protective cloth and accessories
• Health information and communication back up
HEALTH
programmeEMERGENCIES
Entomological indicators disease incidence
27 November 2017
The actual entomological indicators are all based on densities: Larvae (HI, BI, LI), Pupae (PI) and Adults (HI).
Larvae and Pupae densities are far away from the transmission. These indicators are linked to climatic and social conditions, but cannot be related to diseases incidence.
Adults females densities are more close to transmission, however, the fluctuations of the females abundances is not always directly related to transmission since factors such as duration of life (survival) and immunological status of human population can have more significance.
?
HEALTH
programmeEMERGENCIES
Preparedness plans
27 November 2017
• National preparedness plans in
collaboration with local levels
– Identify human resources needed,
training required
– Entomol/Epi surveillance integrated
– Multi sectoral approach
– Increasing awareness of physicians
(malaria case earlier this year)
• Development of Regional plan
HEALTH
programmeEMERGENCIES
4. Challenges
27 November 2017
• Rapid development of insecticide resistance in mosquitoes
• Educating the public of reduction of sources of standing
water
• Major commercial investment is needed for vaccine
development for Zika and Chikungunya.
• Difficulty in predicting future outbreaks making it difficult to
do efficacy trials and future markets.
• Improved surveillance and Point-of-care diagnostics
HEALTH
programmeEMERGENCIES
5. Next Steps
27 November 2017
• Conceptual framework is needed for Aedes-borne diseases
– Change from disease specific programs to comprehensive approach
– End points differ, specific treatments and vaccines. Upstream is same.
– More efficient than developing specific antiviral drugs, vaccines
• Further research on: animal reservoirs, natural history of disease,
global burden
• Innovative methods, tools for vector control
• Development of laboratory diagnostics urgently needed